Extendicare (TSE:EXE) Announces Earnings Results

Extendicare (TSE:EXE) released its quarterly earnings results on Thursday. The company reported C$0.41 earnings per share for the quarter, FiscalAI reports. The firm had revenue of C$627.84 million during the quarter. Extendicare had a return on equity of 36.33% and a net margin of 6.13%.

Extendicare Trading Up 1.2%

EXE stock traded up C$0.33 during midday trading on Friday, reaching C$27.61. The stock had a trading volume of 579,144 shares, compared to its average volume of 446,865. The firm has a market cap of C$2.62 billion, a price-to-earnings ratio of 21.14 and a beta of 1.31. Extendicare has a twelve month low of C$15.80 and a twelve month high of C$39.14. The company has a quick ratio of 0.98, a current ratio of 0.75 and a debt-to-equity ratio of 159.54. The business has a fifty day simple moving average of C$28.92 and a two-hundred day simple moving average of C$30.02.

Extendicare Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Monday, November 16th. Investors of record on Monday, November 16th will be given a $0.0441 dividend. This represents a $0.53 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Friday, October 30th. Extendicare’s dividend payout ratio (DPR) is presently 39.23%.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on EXE. Royal Bank Of Canada raised their target price on Extendicare from C$38.00 to C$39.00 and gave the company an “outperform” rating in a research note on Friday, August 14th. National Bank Financial reduced their price target on shares of Extendicare from C$45.00 to C$40.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 21st. Canaccord Genuity Group increased their price objective on shares of Extendicare from C$37.00 to C$44.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Finally, Desjardins dropped their target price on shares of Extendicare from C$40.00 to C$39.00 and set a “buy” rating for the company in a research note on Monday, August 10th. Seven analysts have rated the stock with a Buy rating. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of C$37.00.

Extendicare Company Profile

Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of the growing seniors’ population, inspired by our mission to provide people with the care they need, wherever they call home. We deliver more than 27 million hours of home health care services annually, operate a network of 97 long-term care homes (58 owned, 39 under management contracts), and provide group purchasing services to third parties representing approximately 161,700 beds across Canada.